NTBL (Notable Labs, Ltd.) Earnings per share growth rate in current year

Corporate emblem and logo of Notable Labs Corp (NTBL)

Notable Labs, Ltd. (NTBL) is scaling its IT system for predicting drug efficacy to capture a share of the oncology market. The relative annual growth in net income per share illustrates the dynamics of this expansion, where 28.50 serves as the final level marker. Stable management is successfully implementing live-cell screening, strengthening confidence through biotech partnerships. Leadership is focusing on clinical validation of precision therapy selection for treating complex forms of cancer.

NTBL - Notable Labs, Ltd. Earnings per share growth in current year over the range 02/21/2024 - 11/02/2024

Financial and market metric breakdowns for notablelabs.com (NTBL)

- business market valuation indicators:
Fundamental valuation:Notable Labs Corp, NTBL
Flagship merchandise of Notable Labs, Ltd.

This indicator measures the year-over-year dynamics of net income per share, determining the efficiency of business monetization and the growth rate of real income. The localization of R&D in the US and the absence of trade barriers for Notable Labs, Ltd. (NTBL) make the YoY net income per share change ratio a transparent tool for assessing operational stability. The positive trend confirms the capitalization of the technological advantage in personalized oncology therapy.

Main competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|Net earnings per one share growth for the current year GDTC (CytoMed)|Curis - Earnings growth in current year|APLM: Earnings per share growth in current year|Tharimmune (THAR) - Earnings per share growth in current year|Net earnings per share growth this year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth in current year|Calidi Biotherapeutics (CLDI) - Expected net earnings per share growth this year|Earnings growth in current year SBFM|Earnings per share growth in current year XBIO (Xenetic Biosciences, Inc.)|Earnings growth in current year SLRX (salariuspharma.com)|PPBT - Net earnings per share growth this year|AONC - Earnings per share growth in current year|Earnings per share increase in current year BGNE (BeOne Medicines)|CKPT: Earnings growth in current year|Elevation Oncology Inc. (ELEV) - Earnings growth in current year|ICAD (iCAD) - Earnings growth in current year|Earnings growth in current year ikenaoncology.com|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma